Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J McKenna

Showing results (1-10 of 337) with videos related to

Pageof 34
Sort By:
Clinical Cardiology|March 1, 1988
Noninvasive assessment and management of the patient at high risk of sudden cardiac deathW J McKenna
Cardiovascular Clinics|January 1, 1988
The natural history of hypertrophic cardiomyopathyW J McKenna
Cardiologia (Rome, Italy)|December 1, 1993
Hypertrophic cardiomyopathy: an updateW J McKenna
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|June 27, 2000
The future in hypertrophic cardiomyopathy: important clues and potential advances from an understanding of the genotype phenotype relationshipW J McKenna
British Journal of Clinical Practice. Supplement|April 1, 1986
Amiodarone and the cardiomyopathiesW J McKenna
European Heart Journal|November 1, 1983
Arrhythmia and prognosis in hypertrophic cardiomyopathyW J McKenna
Drugs|March 1, 1985
Does treatment influence the natural history of patients with hypertrophic cardiomyopathy?W J McKenna
European Heart Journal|June 14, 2000
Digoxin-like immunoreactive substances in hypertrophic cardiomyopathyN Mahon, W J Mckenna
Herz|April 1, 1985
[Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences]W J McKenna, A Kleinebenne
Journal of the American College of Cardiology|September 14, 1999
Milking in hypertrophic cardiomyopathyF Alfonso, W J McKenna
Pageof 34

Showing results (1-10 of 337) with videos related to

Sort By:
Pageof 34
Clinical Cardiology|March 1, 1988
Noninvasive assessment and management of the patient at high risk of sudden cardiac deathW J McKenna
Cardiovascular Clinics|January 1, 1988
The natural history of hypertrophic cardiomyopathyW J McKenna
Cardiologia (Rome, Italy)|December 1, 1993
Hypertrophic cardiomyopathy: an updateW J McKenna
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|June 27, 2000
The future in hypertrophic cardiomyopathy: important clues and potential advances from an understanding of the genotype phenotype relationshipW J McKenna
British Journal of Clinical Practice. Supplement|April 1, 1986
Amiodarone and the cardiomyopathiesW J McKenna
European Heart Journal|November 1, 1983
Arrhythmia and prognosis in hypertrophic cardiomyopathyW J McKenna
Drugs|March 1, 1985
Does treatment influence the natural history of patients with hypertrophic cardiomyopathy?W J McKenna
European Heart Journal|June 14, 2000
Digoxin-like immunoreactive substances in hypertrophic cardiomyopathyN Mahon, W J Mckenna
Herz|April 1, 1985
[Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences]W J McKenna, A Kleinebenne
Journal of the American College of Cardiology|September 14, 1999
Milking in hypertrophic cardiomyopathyF Alfonso, W J McKenna
Pageof 34